Madame Bioscience PCL Cash Flow Statement

Financials in millions THB. Fiscal year is January - December.

Millions THB. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	45.77	-331.63	-405.81	-422.31	-152.43
Depreciation & Amortization	96.94	90.75	107.02	90.33	93.68
Other Amortization	0.14	0.81	0.81	1.65	1.87
Loss (Gain) From Sale of Assets	80.74	2.7	-0.31	22.69	-14.46
Asset Writedown & Restructuring Costs	17.07	-1.31	198.82	26.99	127.86
Loss (Gain) From Sale of Investments	-	98.01	-	-	-
Provision & Write-off of Bad Debts	67.96	0.13	-0.09	-1.82	2.54
Other Operating Activities	-316.08	279.56	53.4	44.07	-19.27
Change in Accounts Receivable	106.8	-4.34	-28.24	74.36	-76.52
Change in Inventory	95.48	72.63	50.92	95.04	-122.61
Change in Accounts Payable	-156.89	13.64	71.79	-79.54	139.08
Change in Other Net Operating Assets	-3.26	6.06	23.68	-16.12	-77.85
Operating Cash Flow	39.72	227.01	71.98	-163.44	-98.48
Operating Cash Flow Growth	-82.50%	215.36%	-	-	-
Capital Expenditures	-41.49	-15.39	-39.61	-144.02	-206.38
Sale of Property, Plant & Equipment	4.39	1.41	6.74	0.17	1.41
Cash Acquisitions	-160.46	-	-	-484.08	-
Divestitures	-	-	-	-	84.43
Other Investing Activities	17.45	1.73	-84.9	-27.78	-
Investing Cash Flow	-180.1	-12.25	-117.77	-655.71	-120.53
Short-Term Debt Issued	389.29	-	-	58.43	628.62
Long-Term Debt Issued	301.75	9.89	-	386.11	135.08
Total Debt Issued	691.04	9.89	-	444.54	763.7
Short-Term Debt Repaid	-437.45	-1.96	-34.86	-	-598.89
Long-Term Debt Repaid	-275.45	-205.73	-83.49	-21.77	-47.33
Total Debt Repaid	-712.91	-207.69	-118.36	-21.77	-646.22
Net Debt Issued (Repaid)	-21.87	-197.8	-118.36	422.76	117.48
Issuance of Common Stock	116.16	73.83	-	646.27	103.28
Other Financing Activities	136.16	-44.94	-54.22	-38.45	-60.31
Financing Cash Flow	230.45	-168.9	-172.57	1,031	160.45
Net Cash Flow	90.07	45.85	-218.35	211.43	-58.56
Free Cash Flow	-1.77	211.62	32.37	-307.46	-304.86
Free Cash Flow Growth	-	553.65%	-	-	-
Free Cash Flow Margin	-0.12%	9.97%	1.41%	-13.80%	-16.37%
Free Cash Flow Per Share	-0.00	0.34	0.05	-0.51	-0.76
Cash Interest Paid	37.76	44.94	54.22	38.45	10.31
Cash Income Tax Paid	2.68	1.15	0.83	14.46	3.98
Levered Free Cash Flow	41.08	184.59	50.55	-216.02	-315.95
Unlevered Free Cash Flow	61.52	216.42	88.74	-189.69	-309.35
Change in Working Capital	42.14	87.98	118.15	73.73	-137.9

Source: S&P Global Market Intelligence. Standard template. Financial Sources.